Items where Author is "Schneider, Peter"

Article

Uyl-de Groot, Carin A.; Xander, Nicolas S.H.; Belleman, Tom; Burger, Emily A.; Doeswijk, Robin; Durand-Zaleski, Isabelle; Geisler, Benjamin P.; Groene, Oliver; Hendrickx, Anne; Henkel, Pia S.; Heine, Renaud; Huić, Mirjana; Melli, Mauro; Morgan, Kate; Racovita, Monica; Quinonez, Gautier; Rutten-van Mölken, Maureen P.M.H.; Tesař, Tomáš; Thielen, Frederick W.; Schneider, Peter; Salcher-Konrad, Maximilian; Wu, Yansi; Aas, Eline (2026): Bridging Affordability and Sustainability of Health Innovations via Novel Pricing, Cost-effectiveness, and Reimbursement Models to Improve Patient Access: The ASCERTAIN Project. Health Policy and Technology. p. 101155

Xander, Anne; Belleman, Tom; Salcher-Konrad, Maximilian; Hendrickx, Anne; Chen, Jeffrey; Klein Gebbink, Anne-Sophie; Schneider, Peter; Schneider, Peter; Morgan, Kate; Groene, Oliver; Durand-Zaleski, Isabelle; Thielen, Frederick W.; Uyl-de Groot, Carin A. (2025): Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review. The European Journal of Health Economics.

Salcher-Konrad, Maximilian; Hendrickx, Anne; Schneider, Peter; Zimmermann, Nina (2024): Defining fair prices for new health technologies. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Schneider, Peter; Salcher-Konrad, Maximilian; Vogler, Sabine (2024): European comparison of prices for off-patent medicines – findings for 16 countries and implications for methodological choices. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Zimmermann, Nina; Schneider, Peter; Paknutova, Svitlana; Piniazhko, Oresta (2024): Evaluation of the external price referencing (EPR) policy for the National Essential Medicines List in Ukraine. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Schneider, Peter; Salcher-Konrad, Maximilian; Fischer, Stefan; Heindl, Bettina; Habl, Claudia (2023): HPR148 Bio-Hybrid Medicinal Products: Widening Access or Product Differentiation? Value in Health, 26 (12). p. 279

Salcher-Konrad, Maximilian; Zimmermann, Nina; Schneider, Peter; Hendrickx, Anne (2023): HPR164 What Is a Fair Price? A Review of Definitions for Fair Prices of Health Technologies. Value in Health, 26 (12). p. 282

Vogler, Sabine; Schneider, Peter; Zuba, Martin; Busse, Reinhard; Panteli, Dimitra (2021): Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure. Frontiers in Pharmacology, 12.

Vogler, Sabine; Schneider, Peter; Lepuschütz, Lena (2020): Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation. Cost Effectiveness and Resource Allocation, 18 (51). pp. https://doi.org/10.1186/s12962-020-00247-3

Habl, Claudia; Németh, Gergely; Schneider, Peter (2019): How the Euripid Collaboration contributes to the affordability of medicines in Europe. Journal of Pharmacy Policy and Practice, 12 (3). ISSN 2052-3211

Vogler, Sabine; Bak Pedersen, Hanne; Dedet, Guillaume; Schneider, Peter (2019): Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan. International Journal for Equity in Health, 18 (89). ISSN 1475-9276

Vogler, Sabine; Schneider, Peter (2019): Assessing Data Sources for Medicine Price Studies. International Journal of Technology Assessment in Health Care, 35 (2). pp. 106-115

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2019): Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. PharmacoEconomics - Open (3). pp. 303-309

Habl, Claudia; Schneider, Peter; Németh, Gergely; Šebesta, Robin (2018): Euripid Collaboration Guidance Principles for External Reference Pricing in Europe. Track Health systems and health care. The European Journal of Public Health, 28 (4).

Book Section

Fischer, Katja; Gehart, Norbert; Krawinkler, Gerald; Kollaritsch, Herwig; Nagel, Anna; Paulke-Korinek, Maria; Röbl, Klara; Ruggier, Lena; Schneider, Peter; Szell, Marton; Zwiauer, Karl (2022): Impfstoffe und Impfung. In: Variantenmanagementplan Konsolidierte Fassung der Ergebnisse des Expert:innenworkshops, Überarbeitungen der GÖG sowie Anmerkungen GECKO, Bundesländer und weiterer Systempartner:innen. Bundeskanzleramt Österreich, Wien, pp. 27-39

Vogler, Sabine; Schneider, Peter; Panteli, Dimitra; Busse, Reinhard (2020): Biosimilars in Deutschland und im europäischen Vergleich – Marktsteuerungsmechanismen und Einsparpotenziale. In: Arzneiverordnungs-Report 2020. Springer, Berlin, doi.org/10.1007 ISBN 978-3-662-62168-4

Vogler, Sabine; Schneider, Peter; Panteli, Dimitri; Busse, Reinhard (2019): Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale. In: Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg

Monograph

Schneider, Peter; Salcher-Konrad, Maximilian (2025): Internationale Preisanalyse von Medikamenten im patentabgelaufenen Markt. Gesundheit Österreich, Wien

Salcher-Konrad, Maximilian; Schneider, Peter; Zimmermann, Nina; Hendrickx, Anne (2025): Scoping review of definitions for fair prices of new health technologies. European Union

Vogler, Sabine; Schneider, Peter; Fischer, Stefan; Haasis, Manuel Alexander; Heindl, Bettina; Windisch, Friederike (2021): Preisvergleich ausgabenstarker Arzneispezialitäten 2019. Gesundheit Österreich, Wien

Schneider, Peter; Fischer, Stefan; Heindl, Bettina (2021): Internationale Preisanalyse von Medikamenten im patentabgelaufenen Markt. Studienprotokoll. Gesundheit Österreich, Wien

Vogler, Sabine; Habimana, Katharina; Bauer, Eveli; Schneider, Peter; Haasis, Manuel Alexander (2021): Assessment of Centralised Procurement of Medicines in Portugal. Gesundheit Österreich, Wien

Vogler, Sabine; Habimana, Katharina; Bauer, Eveli; Schneider, Peter; Haasis, Manuel Alexander (2021): Avaliação das Aquisições Centralizadas dos Medicamentos em Portugal – Relatório de Síntese. Gesundheit Österreich, Wien

Windisch, Friederike; Haasis, Manuel Alexander; Schneider, Peter; Vogler, Sabine (2019): Preisvergleich ausgabenstarker Arzneispezialitäten 2019 - Studienprotokoll. Gesundheit Österreich, Wien

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2019): Estimating Real Prices of Medicines used in Hospitals - Study protocol. Gesundheit Österreich, Wien

Habl, Claudia; Schneider, Peter; Németh, Gergely; Šebesta, Robin (2018): Euripid Guidance Document on External Reference Pricing (ERP). European Commission, Consumer, Health and Food Executive Agency (Chafea), Brussels

Schneider, Peter; Vogler, Sabine; Zimmermann, Nina; Zuba, Martin (2018): Preisvergleich ausgabenstarker Arzneispezialitäten 2017. Gesundheit Österreich, Wien

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2017): Price comparison of high-cost medicines 2017.Study protocol. Gesundheit Österreich, Vienna

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2016): Preisvergleich kostenintensiver Arzneimittel 2015. Gesundheit Österreich GmbH, Wien

Panteli, Dimitra; Arickx, Francis; Cleemput, Irina; Dedet, Guillaume; Eckhardt, Helene; Fogarty, Emer; Gerkens, Sophie; Henschke, Cornelia; Hislop, Jennifer; Jommi, Claudio; Kaitelidou, Daphne; Kawalec, Pawel; Keskimäki, Ilmo; Kroneman, Madelon; Bastida, Julio Lopez; Barros, Pedro Pita; Ramsberg, Joakim; Schneider, Peter; Spillane, Susan; Vogler, Sabine; Vuorenkoski, Lauri; Kildemoes, Helle Wallach; Wouters, Olivier; Busse, Reinhard (2016): Pharmaceutical regulation in 15 European countries. Review. European Observatory on Health Systems and Policies

Vogler, Sabine; Lepuschütz, Lena; Schneider, Peter; Stühlinger, Verena (2015): Study on enhanced cross-country coordination in the area of pharmaceutical product pricing. Final report. Gesundheit Österreich, Wien

Fröschl, Barbara; Antony, Katharina; Pertl, Daniela; Schneider, Peter (2015): Nicht-medikamentöse Prävention und Therapie von Alzheimer-Demenz und gemischter Demenz (2015). Gesundheit Österreich GmbH, Wien

Ostermann, Herwig; Renner, Anna-Theresa; Bobek, Julia; Schneider, Peter; Vogler, Sabine (2015): A cost/benefit analysis of selfcare systems in the European Union. European Commission, DG Sante

Conference or Workshop Item

Kandler, Valentin; Fischer, Stefan; Schneider, Peter (2025): Can Adalimumab serve as 'Big Mac Index' for pharmaceutical prices? Poster. ISPOR Europe 2025, 10. November 2025, Glasgow

Salcher-Konrad, Maximilian; Hendrickx, Anne; Schneider, Peter; Zimmermann, Nina (2024): Defining fair prices for new health technologies. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Zimmermann, Nina; Schneider, Peter; Paknutova, Svitlana; Piniazhko, Oresta (2024): Evaluation of the external price referencing (EPR) policy for the National Essential Medicines List in Ukraine. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 26.-26. April 2024, Wien

Salcher-Konrad, Maximilian; Schneider, Peter; Zimmermann, Nina; Hendrickx, Anne (2024): Key insights from a review of fair pricing definitions. ASCERTAIN Consortium Meeting, 16. Jänner 2024, online

Schneider, Peter; Salcher-Konrad, Maximilian; Fischer, Stefan; Heindl, Bettina; Habl, Claudia (2023): Bio-hybrid medicinal products – Widening access or product differentiation? Posterpräsentation. ISPOR Europe, 14. November 2023, Kopenhagen

Salcher-Konrad, Maximilian; Zimmermann, Nina; Schneider, Peter; Hendrickx, Anne (2023): What is a fair price? A review of definitions for fair prices of health technologies. Posterpräsentation. ISPOR Europe, 14. November 2023, Kopenhagen

Schneider, Peter (2022): Biosimilar Policies in European Countries. Biosimilar medicines - Multistakeholder Event, 13. Dezember 2022, Brüssel

Schneider, Peter (2022): An analysis of price developments after patent expiration. virtual Winter Meeting - Utrecht University, 13. Jänner 2022, online

Mathis-Edenhofer, Stefan; Schneider, Peter; Trauner, Florian (2022): Optimierungspotenziale beim Einsatz von Covid-19-Tests unter Berücksichtigung von Immunität, Vulnerabilität, Streupotenzial, Infektiosität und Inzidenz bei Test-Zielgruppen. 25. ÖGPH-Jahrestagung, 17. Mai 2022, online

Schneider, Peter (2020): How much can biosimilars contribute to savings in the German health system? 5. Konferenz der Austrian Health Economics Association (ATHEA), 28. Februar 2020, Wien

Schneider, Peter; Rainer, Lukas; Zuba, Martin; Vogler, Sabine (2020): An analysis of price developments of biological medicines after patent expiration. Accepted Abstract. Euhea Conference 2020, 9. Juli 2020, Virtual conference

Vogler, Sabine; Schneider, Peter (2019): Choosing the right medicines for price comparisons - Analysis of prices of pharmaceutical presentations of the same active ingredient. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Schneider, Peter; Zimmermann, Nina; Lepuschütz, Lena; Vogler, Sabine (2019): Estimating price developments of biological medicines during market exclusivity. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Schneider, Peter; Habl, Claudia; Németh, Gergely (2019): Ex-post analysis of medicines subject to Managed-Entry-Agreements (MEAs) – a feasible approach for monitoring and price analyses. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Vogler, Sabine; Schneider, Peter (2019): Impact of the external price referencing methodology (EPR) on medicine prices – Simulation of existing EPR models. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Schneider, Peter (2019): External Price Referencing (EPR) - Practice and challenges. Meeting of the Nordic Council, 15. Mai 2019, Webinar

Schneider, Peter (2019): Entwicklungen in Europa zu Preisbildung und Erstattung. imh-Konferenz "Biosimilar", 20. März 2019, Wien

Schneider, Peter (2019): There is no such thing as a biosimilar patent cliff?!? - An analysis of price development of biological medicines after patent expiration. 4. Konferenz der Austrian Health Economics Association (ATHEA), 1. März 2019, Wien

Habl, Claudia; Németh, Gergely; Schneider, Peter (2019): How the Euripid Collaboration contributes to the affordability of medicines in Europe. Posterpräsentation. 12. European Public Health Conference 2019, 20. bis 23. November 2019, Marseille

Schneider, Peter (2018): Das Österreichische Arzneimittelsystem (im Vergleich zu Deutschland). Studienbesuch FH Ostfalia, 19. September 2018, Ostfalia

Habl, Claudia; Schneider, Peter; Németh, Gergely; Šebesta, Robin (2018): Euripid Collaboration Guidance Principles for External Reference Pricing in Europe. Track Health systems and health care. European Public Health Conference 2018, 29. November 2018, Ljubliana

Schneider, Peter (2018): Pharmacy Reimbursement I – Overview European Systems. EU Ratspräsidentschaft, CAPR Meeting, 26. September 2018, Brüssel

Vogler, Sabine; Schneider, Peter (2018): Reimbursement for medicines - Similarities and differences of reference price systems in six European countries. EuHEA (European Health Association) Conference, 13. Dezember 2018, Maastricht

Haasis, Manuel Alexander; Schneider, Peter (2018): A Review of price studies for generic and biosimilar medicines. EUHEA Conference, 12. Juli 2018, Maastricht

Ostermann, Herwig; Bobek, Julia; Renner, Anna; Schneider, Peter; Vogler, Sabine (2016): A cost/benefit analysis of self-care initiatives in the European Union – Who’s better off, who’s worse off? EuHEA Conference 2016, 14. Juli 2016, Hamburg

Book

Schneider, Peter (2016): Pharmaceutical pricing and reimbursement reform in Kyrgyzstan. WHO Regional Office for Europe, Copenhagen ISBN 9789289052191